Related Experiment Video
Updated: Feb 22, 2026

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
Published on: July 14, 2015
Disease Association and Druggability of WD40 Repeat Proteins
Richard Song1, Zhong-Duo Wang1, Matthieu Schapira1,2
1Structural Genomics Consortium, University of Toronto , Toronto, Ontario M5G 1L7, Canada.
Abstract:
WD40 repeat (WDR) domains are protein interaction scaffolds that represent one of the largest protein families in human, and a first WDR inhibitor-an allosteric antagonist of polycomb repressive complex 2-just entered the clinic. A systematic analysis of the CORUM database of protein complexes shows that WDR is the most represented domain in transcriptional regulation and one of the most prevalent in the ubiquitin proteasome system, two pathways of high relevance to drug discovery. Parsing the literature and the vulnerability of cancer cell lines to CRISPR knockout indicates that WDR proteins are targets of interest in oncology and other disease areas. A quantitative analysis of WDR structures reveals that druggable binding pockets can be found on multiple surfaces of these multifaceted protein interaction platforms. These data support the development of chemical probes to further interrogate WDR proteins as an emerging therapeutic target class.
Insights
WD40 repeat (WDR) domains are crucial protein scaffolds involved in gene regulation and the ubiquitin system. These versatile protein interaction platforms present druggable targets for developing novel cancer therapies.
Area of Science:
- Biochemistry and Molecular Biology
- Structural Biology
- Pharmacology
Background:
- WD40 (WDR) repeat domains form large protein families and are key interaction scaffolds.
- A WDR inhibitor targeting polycomb repressive complex 2 has recently entered clinical trials.
- WDR domains are highly represented in transcriptional regulation and the ubiquitin proteasome system.
Purpose of the Study:
- To systematically analyze the role and therapeutic potential of WD40 repeat proteins.
- To investigate the druggability of WDR proteins based on structural analysis.
- To support the development of chemical probes for WDR protein targets.
Main Methods:
- Systematic analysis of the CORUM database of protein complexes.
- Literature review and analysis of cancer cell line vulnerability to CRISPR knockout.
- Quantitative analysis of WD40 repeat protein structures to identify binding pockets.
Main Results:
- WD40 repeat domains are the most represented in transcriptional regulation and prevalent in the ubiquitin proteasome system.
- WDR proteins are identified as targets of interest in oncology and other disease areas based on literature and CRISPR data.
- Druggable binding pockets are present on multiple surfaces of WD40 repeat proteins.
Conclusions:
- WD40 repeat proteins represent an emerging therapeutic target class.
- The structural and functional data support the development of chemical probes to target WDR proteins.
- Targeting WDR proteins holds promise for drug discovery in oncology and beyond.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

